Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electric Stimulation Therapy | 5 | 2018 | 103 | 1.090 |
Why?
|
| Epilepsy, Temporal Lobe | 12 | 2017 | 88 | 1.070 |
Why?
|
| Electroencephalography | 26 | 2021 | 864 | 1.030 |
Why?
|
| Epilepsy | 11 | 2021 | 873 | 0.940 |
Why?
|
| Anticonvulsants | 4 | 2013 | 378 | 0.920 |
Why?
|
| Epilepsies, Partial | 9 | 2019 | 91 | 0.750 |
Why?
|
| Implantable Neurostimulators | 2 | 2018 | 18 | 0.690 |
Why?
|
| Temporal Lobe | 6 | 2018 | 113 | 0.670 |
Why?
|
| Epilepsy, Post-Traumatic | 4 | 2018 | 11 | 0.640 |
Why?
|
| Death, Sudden | 1 | 2018 | 45 | 0.570 |
Why?
|
| Epilepsy, Frontal Lobe | 5 | 2013 | 10 | 0.560 |
Why?
|
| Brain Injuries | 4 | 2009 | 769 | 0.500 |
Why?
|
| Brain | 14 | 2019 | 2996 | 0.490 |
Why?
|
| Mental Recall | 1 | 2015 | 143 | 0.470 |
Why?
|
| Gyrus Cinguli | 2 | 2013 | 116 | 0.420 |
Why?
|
| Breast Feeding | 1 | 2013 | 219 | 0.380 |
Why?
|
| Deep Brain Stimulation | 4 | 2019 | 411 | 0.380 |
Why?
|
| Seizures | 7 | 2021 | 870 | 0.370 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 227 | 0.360 |
Why?
|
| Drug Resistant Epilepsy | 3 | 2019 | 203 | 0.350 |
Why?
|
| Periventricular Nodular Heterotopia | 2 | 2019 | 8 | 0.330 |
Why?
|
| Functional Laterality | 6 | 2015 | 184 | 0.310 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 711 | 0.300 |
Why?
|
| Electrocorticography | 2 | 2019 | 69 | 0.290 |
Why?
|
| Coma | 1 | 2007 | 56 | 0.280 |
Why?
|
| Brain Waves | 2 | 2019 | 47 | 0.270 |
Why?
|
| Adult | 32 | 2021 | 29554 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2019 | 3560 | 0.260 |
Why?
|
| Neurosurgical Procedures | 3 | 2013 | 301 | 0.260 |
Why?
|
| Cerebral Cortex | 6 | 2019 | 452 | 0.240 |
Why?
|
| Neuropsychological Tests | 5 | 2015 | 925 | 0.230 |
Why?
|
| Middle Aged | 22 | 2021 | 26884 | 0.220 |
Why?
|
| Male | 35 | 2021 | 61317 | 0.210 |
Why?
|
| Sclerosis | 2 | 2015 | 34 | 0.200 |
Why?
|
| Apolipoproteins E | 1 | 2003 | 192 | 0.200 |
Why?
|
| Female | 31 | 2020 | 66577 | 0.190 |
Why?
|
| Young Adult | 10 | 2018 | 9023 | 0.190 |
Why?
|
| Neurology | 2 | 2015 | 107 | 0.180 |
Why?
|
| Humans | 49 | 2021 | 124705 | 0.180 |
Why?
|
| Encephalitis Virus, St. Louis | 1 | 2000 | 18 | 0.170 |
Why?
|
| Electrodes, Implanted | 6 | 2019 | 168 | 0.170 |
Why?
|
| Encephalitis, St. Louis | 1 | 2000 | 20 | 0.170 |
Why?
|
| Neocortex | 2 | 2019 | 72 | 0.170 |
Why?
|
| Frameshift Mutation | 1 | 2020 | 179 | 0.160 |
Why?
|
| Bradycardia | 1 | 2019 | 61 | 0.160 |
Why?
|
| RNA Splicing | 1 | 2020 | 226 | 0.150 |
Why?
|
| Motor Cortex | 2 | 1996 | 77 | 0.150 |
Why?
|
| Disease Outbreaks | 1 | 2000 | 318 | 0.140 |
Why?
|
| Adolescent | 18 | 2018 | 19221 | 0.140 |
Why?
|
| Quality Improvement | 2 | 2015 | 639 | 0.140 |
Why?
|
| Videotape Recording | 4 | 2004 | 57 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 546 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 573 | 0.130 |
Why?
|
| Prospective Studies | 7 | 2021 | 6132 | 0.120 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2015 | 61 | 0.120 |
Why?
|
| Dominance, Cerebral | 3 | 2017 | 56 | 0.120 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2015 | 32 | 0.120 |
Why?
|
| Organ Size | 1 | 2015 | 436 | 0.120 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 502 | 0.110 |
Why?
|
| Status Epilepticus | 2 | 2000 | 143 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 1113 | 0.110 |
Why?
|
| Aged | 7 | 2019 | 19830 | 0.110 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 5154 | 0.110 |
Why?
|
| Memory | 2 | 2009 | 361 | 0.100 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2018 | 381 | 0.100 |
Why?
|
| Brain Mapping | 5 | 2017 | 398 | 0.100 |
Why?
|
| Hippocampus | 4 | 2019 | 824 | 0.100 |
Why?
|
| Treatment Outcome | 9 | 2015 | 12364 | 0.100 |
Why?
|
| Laughter | 1 | 2011 | 10 | 0.090 |
Why?
|
| Electric Stimulation | 2 | 2011 | 326 | 0.090 |
Why?
|
| Unconsciousness | 1 | 2011 | 17 | 0.090 |
Why?
|
| Nephrolithiasis | 1 | 2010 | 14 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 1260 | 0.090 |
Why?
|
| Fructose | 1 | 2010 | 62 | 0.090 |
Why?
|
| Retrospective Studies | 10 | 2015 | 16263 | 0.080 |
Why?
|
| Academies and Institutes | 1 | 2011 | 83 | 0.080 |
Why?
|
| Veterans | 2 | 2021 | 1749 | 0.080 |
Why?
|
| Pentobarbital | 1 | 1990 | 20 | 0.080 |
Why?
|
| Neurons | 1 | 2020 | 1932 | 0.080 |
Why?
|
| Phenytoin | 1 | 1990 | 64 | 0.080 |
Why?
|
| Fear | 1 | 2011 | 200 | 0.080 |
Why?
|
| Heterozygote | 2 | 2020 | 671 | 0.080 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 605 | 0.080 |
Why?
|
| Benzodiazepines | 1 | 1990 | 99 | 0.080 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2009 | 10 | 0.080 |
Why?
|
| Head Injuries, Penetrating | 1 | 2009 | 6 | 0.080 |
Why?
|
| Diffuse Axonal Injury | 1 | 2009 | 10 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 163 | 0.080 |
Why?
|
| Rehabilitation Centers | 1 | 2007 | 36 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2011 | 389 | 0.070 |
Why?
|
| Cicatrix | 1 | 2009 | 124 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 3415 | 0.070 |
Why?
|
| Psychotropic Drugs | 1 | 2007 | 122 | 0.070 |
Why?
|
| Memory Disorders | 1 | 2009 | 236 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 584 | 0.060 |
Why?
|
| Brain Concussion | 1 | 2009 | 229 | 0.060 |
Why?
|
| Epilepsy, Complex Partial | 2 | 2017 | 13 | 0.060 |
Why?
|
| Time Factors | 3 | 2015 | 6323 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2007 | 445 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2007 | 402 | 0.060 |
Why?
|
| Age of Onset | 4 | 2000 | 591 | 0.060 |
Why?
|
| Pattern Recognition, Physiological | 1 | 2004 | 4 | 0.060 |
Why?
|
| Wechsler Scales | 1 | 2004 | 20 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2017 | 759 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 1090 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 2093 | 0.050 |
Why?
|
| Substantia Nigra | 2 | 2000 | 34 | 0.050 |
Why?
|
| Glasgow Outcome Scale | 1 | 2003 | 47 | 0.050 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2003 | 142 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 1326 | 0.050 |
Why?
|
| Drug Implants | 1 | 2002 | 42 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2003 | 724 | 0.050 |
Why?
|
| Epilepsy, Tonic-Clonic | 2 | 2017 | 14 | 0.050 |
Why?
|
| Pregnancy | 1 | 2013 | 7171 | 0.040 |
Why?
|
| Frontal Lobe | 3 | 1996 | 116 | 0.040 |
Why?
|
| Phenotype | 2 | 2009 | 4258 | 0.040 |
Why?
|
| Huntington Disease | 1 | 1982 | 143 | 0.040 |
Why?
|
| Neurosyphilis | 1 | 2000 | 14 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2015 | 1637 | 0.040 |
Why?
|
| Axon Guidance | 1 | 2020 | 3 | 0.040 |
Why?
|
| AIDS Dementia Complex | 1 | 2000 | 12 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2002 | 277 | 0.040 |
Why?
|
| Receptors, GABA-A | 2 | 1995 | 58 | 0.040 |
Why?
|
| Video Recording | 1 | 2021 | 183 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1982 | 470 | 0.040 |
Why?
|
| Prognosis | 1 | 2009 | 4620 | 0.040 |
Why?
|
| Genotype | 2 | 2003 | 2558 | 0.040 |
Why?
|
| Brain Edema | 1 | 2000 | 68 | 0.040 |
Why?
|
| Penicillins | 1 | 2000 | 155 | 0.040 |
Why?
|
| Muscle Hypotonia | 1 | 2020 | 187 | 0.040 |
Why?
|
| Language Development Disorders | 1 | 2020 | 174 | 0.040 |
Why?
|
| Alleles | 1 | 2003 | 1615 | 0.040 |
Why?
|
| Radiography | 1 | 2000 | 815 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2885 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2020 | 351 | 0.040 |
Why?
|
| DNA | 1 | 2003 | 1606 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 701 | 0.040 |
Why?
|
| Zebrafish | 1 | 2020 | 380 | 0.040 |
Why?
|
| Angelman Syndrome | 1 | 1998 | 68 | 0.040 |
Why?
|
| Epilepsy, Partial, Motor | 1 | 2017 | 2 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1998 | 160 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2017 | 69 | 0.030 |
Why?
|
| Persian Gulf Syndrome | 1 | 1997 | 15 | 0.030 |
Why?
|
| Defibrillators, Implantable | 1 | 2019 | 190 | 0.030 |
Why?
|
| Age Factors | 2 | 2000 | 2807 | 0.030 |
Why?
|
| Central Nervous System Diseases | 1 | 1997 | 107 | 0.030 |
Why?
|
| Electrodes | 2 | 1996 | 98 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1998 | 311 | 0.030 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1997 | 124 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2020 | 13882 | 0.030 |
Why?
|
| Base Sequence | 1 | 2020 | 3101 | 0.030 |
Why?
|
| Monitoring, Intraoperative | 1 | 1996 | 133 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 1998 | 612 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2015 | 81 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2015 | 105 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 181 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 3055 | 0.030 |
Why?
|
| Steroids | 1 | 1995 | 201 | 0.030 |
Why?
|
| Propofol | 1 | 1994 | 44 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 1 | 1993 | 44 | 0.030 |
Why?
|
| Neurologic Examination | 3 | 2000 | 193 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 2020 | 1056 | 0.020 |
Why?
|
| Texas | 1 | 2000 | 3561 | 0.020 |
Why?
|
| Brain Neoplasms | 3 | 1994 | 1215 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 2900 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1990 | 257 | 0.020 |
Why?
|
| Risk Factors | 1 | 2003 | 10249 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 6584 | 0.020 |
Why?
|
| Child | 7 | 2013 | 24173 | 0.020 |
Why?
|
| Educational Status | 1 | 2009 | 276 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 632 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 1176 | 0.020 |
Why?
|
| Psychometrics | 1 | 2009 | 673 | 0.010 |
Why?
|
| Automatism | 2 | 1995 | 4 | 0.010 |
Why?
|
| Trauma Severity Indices | 1 | 2004 | 86 | 0.010 |
Why?
|
| Quality of Life | 1 | 2014 | 1936 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 2446 | 0.010 |
Why?
|
| Posture | 2 | 1995 | 154 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 17645 | 0.010 |
Why?
|
| Subdural Space | 2 | 1993 | 4 | 0.010 |
Why?
|
| Putamen | 1 | 1982 | 19 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 1021 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1982 | 96 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1982 | 35 | 0.010 |
Why?
|
| Observer Variation | 2 | 1993 | 299 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1982 | 172 | 0.010 |
Why?
|
| United States | 2 | 2011 | 10866 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 34235 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1995 | 1873 | 0.010 |
Why?
|
| Ligases | 1 | 1998 | 46 | 0.010 |
Why?
|
| Genomic Imprinting | 1 | 1998 | 124 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 1997 | 34 | 0.010 |
Why?
|
| Nystagmus, Pathologic | 1 | 1997 | 22 | 0.010 |
Why?
|
| Vestibular Function Tests | 1 | 1997 | 34 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 109 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1997 | 145 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 1997 | 104 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1998 | 359 | 0.010 |
Why?
|
| Muscimol | 1 | 1995 | 9 | 0.010 |
Why?
|
| Ataxia | 1 | 1997 | 170 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 1080 | 0.010 |
Why?
|
| Autoradiography | 1 | 1995 | 69 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1995 | 32 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1998 | 646 | 0.010 |
Why?
|
| Oligodendroglioma | 1 | 1993 | 22 | 0.010 |
Why?
|
| Ganglioglioma | 1 | 1993 | 22 | 0.010 |
Why?
|
| Arm | 1 | 1993 | 81 | 0.010 |
Why?
|
| Speech | 1 | 1993 | 62 | 0.010 |
Why?
|
| Head | 1 | 1993 | 102 | 0.010 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 1993 | 46 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1993 | 33 | 0.010 |
Why?
|
| Probability | 1 | 1993 | 321 | 0.010 |
Why?
|
| Astrocytoma | 1 | 1993 | 99 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 1997 | 553 | 0.010 |
Why?
|
| Eye | 1 | 1993 | 227 | 0.010 |
Why?
|
| Binding Sites | 1 | 1995 | 1302 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1993 | 147 | 0.010 |
Why?
|
| Dystonia | 1 | 1993 | 171 | 0.010 |
Why?
|
| DNA Methylation | 1 | 1998 | 1008 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1993 | 376 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1993 | 355 | 0.010 |
Why?
|
| Sphenoid Bone | 1 | 1989 | 10 | 0.010 |
Why?
|
| Action Potentials | 1 | 1993 | 502 | 0.010 |
Why?
|
| Equipment Design | 1 | 1992 | 598 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1997 | 3293 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1993 | 1191 | 0.000 |
Why?
|
| Scalp | 1 | 1989 | 57 | 0.000 |
Why?
|
| Infant | 2 | 1995 | 12384 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1993 | 2161 | 0.000 |
Why?
|
| Incidence | 1 | 1993 | 3115 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1993 | 3068 | 0.000 |
Why?
|